BNP Paribas Financial Markets
NMRD

BNP Paribas Financial Markets’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

BNP Paribas Financial Markets’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-255
Closed -$530 – 4799
2022
Q3 		$530 Buy
+255
New +$510 ﹤0.01% 4509

Other funds holding NMRD

TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BNP Paribas Financial Markets's NMRD Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q4 2022, closing a stake of 255 shares — an estimated $530 sold.

BNP Paribas Financial Markets first reported a position in NMRD in Q3 2022 and held it in 1 quarter. The position peaked at $530 in Q3 2022. 16 funds tracked by Wall St. Rank hold NMRD as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining Nemaura Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 255 Nemaura Medical, Inc. Common Stock shares in Q4 2022, an estimated $530.
  • BNP Paribas Financial Markets first reported a position in Nemaura Medical, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's Nemaura Medical, Inc. Common Stock position peaked at $530 in Q3 2022.
  • 16 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.